Monte Rosa Therapeutics
Get Full AccessDescription
- Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. Initially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.
-
Headquarters:40 Guest Street , Boston, Massachusetts, United States
More -
Phone Number:
-
Website: http://www.monterosatx.com
-
Employees:35
-
Revenue:$10 - 50M
-
Legal Name:Monte Rosa Therapeutics
-
Monte Rosa Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Monte Rosa Therapeutics
-
Where are Monte Rosa Therapeutics's Headquarters?
Monte Rosa Therapeutics's Headquarters are in 40 Guest Street ,Boston,Massachusetts,United States
-
What is Monte Rosa Therapeutics's official website?
Monte Rosa Therapeutics's official website is http://www.monterosatx.com
-
What is Monte Rosa Therapeutics's Revenue?
Monte Rosa Therapeutics's revenue is $10 - 50M
-
What is Monte Rosa Therapeutics's NAICS code?
Monte Rosa Therapeutics's NAICS code is 541713
-
How many employees are working in Monte Rosa Therapeutics
Monte Rosa Therapeutics has 35 employees
-
What is Monte Rosa Therapeutics's Industry?
Monte Rosa Therapeutics is in the industry of Biotechnology
-
Who is Monte Rosa Therapeutics's Chief Medical Officer?
Monte Rosa Therapeutics's Chief Medical Officer is Filip Janku
-
Who is Monte Rosa Therapeutics's Chief Financial Officer?
Monte Rosa Therapeutics's Chief Financial Officer is Ajim Tamboli

